InvestorsHub Logo
Followers 137
Posts 22827
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Saturday, 07/26/2014 12:48:10 PM

Saturday, July 26, 2014 12:48:10 PM

Post# of 2205
Has anyone heard

Has anyone heard that Johnson and Johnson may be working with Calimmune regarding a gene therapy to cure HIV???

http://hotcopper.com.au/threads/ann-bit225-reverses-hiv-induced-impairment-of-the-immune-system.2322502/page-30?post_id=13719134#.U9PZODK9KSM

"...HIV gene therapy

ART has significantly decreased the morbidity and mortality of HIV/AIDS. However it does not eradicate HIV infection and there can be complications associated with antiretroviral drugs. A new therapeutic approach involves delivering a protective gene to the cells of an infected person using gene therapy. A recent trial conducted by Johnson & Johnson Australia showed that anti-HIV gene therapy is safe and biologically active. We have continued investigation of gene therapy with researchers at Calimmune, through an ARC Linkage Grant: "Can an anti-HIV gene in blood stem cells protect from immune depletion by HIV?"...."

http://web.maths.unsw.edu.au/~johnm/HIV.html

Good luck and GOD bless,

George
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BNTC News